戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 formation with the phosphate group of the 2'-deoxynucleotide.
2 n kinetics for incorporation of an incorrect deoxynucleotide.
3 s of magnitude less efficiently than natural deoxynucleotides.
4 dducts by B[a]PDE following reaction with 2'-deoxynucleotides.
5 catalyzes the reduction of nucleotides to 2'-deoxynucleotides.
6 says demonstrate that both NH2Y-alpha2s make deoxynucleotides.
7 tracellular dGTP without any effect on other deoxynucleotides.
8 , catalyzes the conversion of nucleotides to deoxynucleotides.
9 14 microg/ml, whereas M1dG fell to 1.4/10(7) deoxynucleotides.
10 oration and removal of natural and unnatural deoxynucleotides.
11 nd can generate products containing up to 32 deoxynucleotides.
12 ophosphates and PP(i), with a preference for deoxynucleotides.
13 xynucleotides were not the same as for the D-deoxynucleotides.
14 s) catalyze the conversion of nucleotides to deoxynucleotides.
15 e ribonucleotide embedded within a series of deoxynucleotides.
16  the equilibrium of allosteric activation by deoxynucleotides.
17 A biosynthesis: conversion of nucleotides to deoxynucleotides.
18 e >200-fold more rapidly than other ribo- or deoxynucleotides.
19  catalyzing the conversion of nucleotides to deoxynucleotides.
20 hetic oligonucleotides containing 4'-thio-2'-deoxynucleotides.
21  reductase (RNR) converts ribonucleotides to deoxynucleotides.
22 2 have significantly reduced ability to make deoxynucleotides.
23 cytosine guanine dinucleotide-enriched oligo-deoxynucleotides.
24 ol alpha), which extends the RNA primer with deoxynucleotides.
25 NA template and extending an RNA primer with deoxynucleotides.
26 el pathway for the prebiotic synthesis of 2'-deoxynucleotides.
27 osite correct (G) and incorrect (A) incoming deoxynucleotides.
28 ency vary inversely with the accumulation of deoxynucleotides.
29 emplate duplexes with 3'-deoxynucleotide, 3'-deoxynucleotide 3'-phosphate, or 3' ribonucleotide termi
30 presence of primer-template duplexes with 3'-deoxynucleotide, 3'-deoxynucleotide 3'-phosphate, or 3'
31                                           2'-Deoxynucleotide 5'-tetraphosphates in which a fluorescen
32 sion of nucleoside diphosphates (NDPs) to 2'-deoxynucleotides, a critical step in DNA replication and
33 ) catalyzes the conversion of nucleotides to deoxynucleotides, a process that requires long-range rad
34 ubsequently, nodes of PCNA that incorporated deoxynucleotide analogs were observed in regions of low-
35 n cognate and near-cognate tRNAs, we made 2'-deoxynucleotide and 2'-fluoro substituted mRNAs, which d
36 e it maintains the balance between guanylate deoxynucleotide and ribonucleotide levels that is pivota
37 cluding MDA, as compared with 3.8 M1dG/10(7) deoxynucleotides and 0.07 microg/ml lipid peroxidation p
38 odified DNA probes, incorporating two pyrene deoxynucleotides and a damaged base, enable the direct,
39  in cancer cells to fuel the biosynthesis of deoxynucleotides and antioxidants and to sustain stress-
40 s) catalyze the conversion of nucleotides to deoxynucleotides and are composed of alpha- and beta-sub
41 es catalyze the conversion of nucleotides to deoxynucleotides and are composed of two subunits: R1 an
42 , enzymes that convert nucleotides (NDPs) to deoxynucleotides and are essential for DNA replication a
43        This enzyme contains approximately 30 deoxynucleotides and can cleave almost any RNA substrate
44 for counting efficiencies of labeled DNA and deoxynucleotides and illustrate the generality of this e
45 he conversion of nucleoside triphosphates to deoxynucleotides and is 100% inactivated by 1 equiv of 2
46 ) catalyzes the conversion of nucleotides to deoxynucleotides and is composed of two subunits: alpha2
47 uction of nucleoside 5'-diphosphates into 2'-deoxynucleotides and is composed of two subunits: alpha2
48 ) catalyzes the conversion of nucleotides to deoxynucleotides and is essential in all organisms.
49 he conversion of nucleoside triphosphates to deoxynucleotides and is rapidly (<30 s) inactivated by 1
50 h 18:0/stearic acid) produced 6.5 M1dG/10(7) deoxynucleotides and no detectable lipid peroxidation pr
51 the availability of pure, well-characterized deoxynucleotides and not a sequence-specific pure DNA st
52 s) catalyze the conversion of nucleotides to deoxynucleotides and require dinuclear metal clusters fo
53 ficient at adding templated and nontemplated deoxynucleotides and ribonucleotides to DNA ends in vitr
54                                The antisense deoxynucleotides and siRNA approach acts via removal of
55 encing in GBM cells reduced levels of NADPH, deoxynucleotides, and glutathione and increased their se
56 acteriophage-encoded RNA polymerase using 3'-deoxynucleotides as chain terminators.
57  results suggest that the potency of adenine deoxynucleotides as co-factors for APAF-1-dependent casp
58            Incorporation of site-specific 2'-deoxynucleotides, as well as phosphorothioate and methyl
59 as documented by more rapid incorporation of deoxynucleotides, associated with earlier increases in c
60 ozyme bound to an inhibitor RNA containing a deoxynucleotide at the cleavage site.
61 A polymerase Pol iota, which misincorporates deoxynucleotides at a high rate.
62 thesis of a series of derivatives containing deoxynucleotides at each position along the D5 strand.
63  variant of pol beta, K289M, misincorporates deoxynucleotides at significantly increased frequencies
64                        The introduction of 3 deoxynucleotides at the 5' terminus of the 2'-methoxy an
65  binds nucleoside diphosphate substrates and deoxynucleotide/ATP allosteric effectors and is the site
66  that phage-augmented NADPH production fuels deoxynucleotide biosynthesis for phage replication, and
67 phage genes involved in the light reactions, deoxynucleotide biosynthesis, and the PPP, including a t
68              A protein, termed mitochondrial deoxynucleotide carrier (DNC), based on its ability to t
69 25A19, which encodes a nuclear mitochondrial deoxynucleotide carrier (DNC), contains a substitution t
70                                  The lack of deoxynucleotides causes replicative stress leading to ac
71 io of PrEP's active metabolites vs competing deoxynucleotides compared to cisgender women and men (P
72  will only occur if the gap is filled with a deoxynucleotide complementary to the wild-type or mutant
73 triphosphate (TP) levels similar to cellular deoxynucleotide concentrations can induce multilog killi
74        Bypass efficiency was proportional to deoxynucleotide concentrations equivalent to those found
75 /z 399 and 497 were observed for all four 2'-deoxynucleotides, corresponding to [(B[a]Ptriol+phosphat
76 efficient than the second, and among natural deoxynucleotides, dATP was the preferred substrate due t
77 ymes that are alone capable of generating 2'-deoxynucleotides de novo and are thus critical in DNA bi
78 vestigate allosteric activation of SAMHD1 by deoxynucleotide-dependent tetramerization and measure ho
79          Collectively, our data suggest that deoxynucleotide-dependent tetramerization contributes to
80 y, RTEL1 deficiency induces tolerance to the deoxynucleotide-depleting drug hydroxyurea, which could
81 tional Xrs2p complex leads to sensitivity to deoxynucleotide depletion and to an inability to efficie
82                 However, under conditions of deoxynucleotide depletion produced by hydroxyurea treatm
83 he half-life of the assembled tetramer after deoxynucleotide depletion varies from minutes to hours d
84 operties of dimerized pentaphosphate-bridged deoxynucleotides (dicaptides) that contain reactive comp
85 ntrols the balance and level of the cellular deoxynucleotide diphosphate pools that are critical for
86 sion of nucleoside 5'-diphosphates (NDPs) to deoxynucleotides (dNDPs).
87  conversion of nucleoside 5'-diphosphates to deoxynucleotides (dNDPs).
88 n of nucleoside 5'-diphosphates (NDPs) to 2'-deoxynucleotides (dNDPs).
89 over saturation kinetics for all 16 possible deoxynucleotide (dNTP) incorporations and for four match
90 overed that incorporation of a complementary deoxynucleotide (dNTP) into a self-primed single-strande
91  phosphorylation, differential effects on 2'-deoxynucleotide (dNTP) pools, and differences in the aff
92 ) catalyze the rate-limiting step of de novo deoxynucleotide (dNTP) synthesis.
93 which subsequently catalyzed the addition of deoxynucleotides (dNTP) containing biotinlated 2'-deoxya
94 es were to analyze pharmacodynamic effect on deoxynucleotides (dNTPs) and to seek relationships betwe
95 se that catalyzes the sequential addition of deoxynucleotides (dNTPs) at the 3'-OH group of an oligon
96 tion of a mixture of natural and fluorescent deoxynucleotides (dNTPs) at the 3'-OH of an RNA-DNA hybr
97 preparation of the corresponding fluorinated deoxynucleotides (dNTPs).
98 strate-recognition domains of seven to eight deoxynucleotides each.
99                                     Terminal deoxynucleotide end-labeling (TUNEL) assays performed on
100                                Terminal nick deoxynucleotide end-labeling-positive apoptotic cells (1
101 yl radical (Fe(III)2-Y*) cofactor to produce deoxynucleotides essential for DNA replication and repai
102 hen this initiation complex is supplied with deoxynucleotides, essentially all of the tRNA is used as
103 yme is comprised of a catalytic domain of 15 deoxynucleotides, flanked by two substrate-recognition d
104 s reveal a preference for guanosine/cytosine deoxynucleotides flanking the cognate CpG.
105 o RNase A pretreatment and requires all four deoxynucleotides for optimal polymerization.
106 tion of large bDNA combs containing all four deoxynucleotides for use as signal amplifiers in nucleic
107 osyl radical (Y122.) cofactor that initiates deoxynucleotide formation.
108 nt of Y731 of R2 with phenylalanine prevents deoxynucleotide formation.
109  with DNA polymerases, can excise mismatched deoxynucleotides from DNA.
110 se containing ribose; purine nucleotides and deoxynucleotides gave more methylglyoxal than did the py
111                                          The deoxynucleotide generated depends on the presence of all
112 double-stranded target derived from standard deoxynucleotides (i.e. beta-anomers).
113 reaks, incorporates both ribonucleotides and deoxynucleotides in a template-directed manner.
114                 The presence of chloride and deoxynucleotides in a total concentration above 10 micro
115 ch catalyze the conversion of nucleotides to deoxynucleotides in all organisms, are an exemplar of ra
116 yze the de novo conversion of nucleotides to deoxynucleotides in all organisms, controlling their rel
117 s) catalyze the conversion of nucleotides to deoxynucleotides in all organisms, providing the monomer
118 s) catalyze the conversion of nucleotides to deoxynucleotides in all organisms.
119 e radical chemistry to reduce nucleotides to deoxynucleotides in all organisms.
120 to several other clinically relevant adenine deoxynucleotides in B-chronic lymphocytic leukemia extra
121 ggest that site-specific incorporation of 3'-deoxynucleotides in CpG DNA modulates immunostimulatory
122 his reversal of the polymerization reaction, deoxynucleotides in DNA are converted to deoxynucleoside
123  The duplex donor DNAs are approximately 300 deoxynucleotides in length and contain only 15 bp of the
124 s, thereby maintaining the proper balance of deoxynucleotides in the cell.
125                  A pre-steady-state burst of deoxynucleotide incorporation (k(obsd) = 1.0 s(-)(1)) in
126 y for the enzymatic reaction during a single deoxynucleotide incorporation event.
127             Steady-state kinetic analyses of deoxynucleotide incorporation indicate that pol eta has
128 re is a hyperbolic dependence of the rate of deoxynucleotide incorporation on the concentration of dC
129 ved with a DNA template, the rate of correct deoxynucleotide incorporation was reduced 25-fold (5.5+/
130                         Endogenous levels of deoxynucleotides increased 24 hours after ara-C infusion
131 merases are defined as such because they use deoxynucleotides instead of ribonucleotides with high sp
132    The misincorporation of non-complementary deoxynucleotides into DNA by pol alpha was substantially
133 on helix was evaluated by introducing single deoxynucleotides into each of the six positions in the h
134 epair in response to the misincorporation of deoxynucleotides into newly synthesized DNA, long before
135 f ribonucleotide 5'-diphosphates to their 2'-deoxynucleotides, is modulated by levels of its M2 subun
136 tion in a viral strategy to control cellular deoxynucleotide levels for efficient replication.
137 tetramerization contributes to regulation of deoxynucleotide levels in cycling cells, whereas in non-
138 h defects in genes involved in mitochondrial deoxynucleotide metabolism or utilization, such as mutat
139 thanol-induced alterations in methionine and deoxynucleotide metabolism.
140 atically digested to its constituent monomer-deoxynucleotide monophosphates (dNMPs), of which there a
141 ase upon Q deprivation is due to the lack of deoxynucleotides needed for DNA synthesis.
142 d (either on the base or phosphate group) 2'-deoxynucleotides of guanine, adenine, cytosine and thymi
143                               Interestingly, deoxynucleotides of Pf1 DNA exhibit sugars in the C2'-en
144         Using the drug-containing and normal deoxynucleotide oligomers (21-base) annealed to M13mp18(
145                         Substitution of a 3'-deoxynucleotide on the scissile strand at position -6 en
146 e DNA lesions, but readily extends from such deoxynucleotides once they have been inserted.
147            We report that LigD POL can add a deoxynucleotide opposite an abasic lesion in the templat
148 ases act sequentially: Pol iota incorporates deoxynucleotides opposite DNA lesions, and Pol zeta func
149    Pol zeta is very inefficient in inserting deoxynucleotides opposite DNA lesions, but readily exten
150 s damage, Pol iota specifically incorporates deoxynucleotides opposite highly distorting or non-instr
151 polymerase I selects its natural substrates, deoxynucleotides, over ribonucleotides by several thousa
152 s specifically insert the hydrophobic pyrene deoxynucleotide (P) opposite tetrahydrofuran (F), an sta
153 g protein-1 (SAMHD1) is a recently described deoxynucleotide phosphohydrolase controlling the size of
154 ation) and the subsequent addition of 2 or 3 deoxynucleotides (polymerization).
155 or the construction of high molecular weight deoxynucleotide polymers.
156 nvolved DNA sequencing of two closely spaced deoxynucleotide polymorphisms.
157              Also, disturbances in bacterial deoxynucleotide pools amplify 5-FU-induced autophagy and
158                    Hydroxyurea also depleted deoxynucleotide pools and increased the incorporation of
159 hibit ribonucleotide reductase and decreased deoxynucleotide pools, were incorporated mainly within r
160 , there was a decline in the cellular purine deoxynucleotide pools.
161  the incorporation of matched and mismatched deoxynucleotides probably reflects the differences in th
162       It controls cell proliferation through deoxynucleotide production and metastatic propensity thr
163                      The pH rate profiles of deoxynucleotide production by these F(n)()Y(356)-R2s are
164 metabolism including energy transduction and deoxynucleotide production catalyzed by ribonucleotide r
165  up a functional unit involved in energy and deoxynucleotide production for phage replication in reso
166 he possibility of an abiotic route to the 2'-deoxynucleotides provides a new perspective on the evolu
167 ) catalyzes the conversion of nucleotides to deoxynucleotides, providing the building blocks for DNA
168 s) catalyze the conversion of nucleotides to deoxynucleotides, providing the monomeric precursors req
169                          The B[a]PDE plus 2'-deoxynucleotide reaction mixtures were purified using so
170 ication that is independent of checkpoint or deoxynucleotide regulation is proposed.
171 V-1 RT manifested itself during ATP-mediated deoxynucleotide removal.
172 *) enzymes that provide the balanced pool of deoxynucleotides required for DNA synthesis and repair i
173 wn for its antiviral activity of hydrolysing deoxynucleotides required for virus replication.
174 igomers containing 2-aminoquinazolin-5-yl 2'-deoxynucleotide residues are reported.
175 s they did for substrates composed solely of deoxynucleotide residues.
176 r DNA replication, but 2) upon addition of a deoxynucleotide results in the conversion of the incorpo
177 oside diphosphate reductase with 2'-azido-2'-deoxynucleotides results in appearance of EPR signals fo
178 ric oligonucleotides composed of a five-base deoxynucleotide sequence flanked by chemically modified
179 nse oligonucleotides composed of a five-base deoxynucleotide sequence flanked on either side by chemi
180 e, PCR competent and able to copy repetitive deoxynucleotide sequences six to seven times more faithf
181 t of each nucleotide in the tetraloop with a deoxynucleotide showed a 16-fold increase in k(cat) for
182                          The method provides deoxynucleotide-specific detection, accurate measurement
183 restores A site binding, it appears that the deoxynucleotide substituted complexes are impaired in th
184 fects in tRNA selection with the multiple 2'-deoxynucleotide substituted mRNA.
185                                     A set of deoxynucleotide substituted versions of this tRNA has be
186 expanded set of misacylated tRNAs and two 2'-deoxynucleotide-substituted mRNAs are used to demonstrat
187 45 different tRNAs, each containing a single deoxynucleotide substitution covering the upper half of
188                         Only four individual deoxynucleotide substitutions blocked splicing activity:
189 ertiary stabilization is increased by single deoxynucleotide substitutions in the exon mimic at every
190            Our results show that multiple 2'-deoxynucleotide substitutions in the mRNA substantially
191 without significantly affecting affinity for deoxynucleotide substrate (K(d)(-dNTP)).
192 ining juxtaposed dC and 5'-phosphorylated dT deoxynucleotides (substrate 1) yielded kcat and kcat/Km
193 '-substituted terminators and compared to 2'-deoxynucleotide substrates (dNTPs).
194  transferase activity, HP could use all four deoxynucleotide substrates, but TTP was clearly favored
195 ings with other nucleoside analogs or normal deoxynucleotides such as dGTP.
196 leoside 5'-diphosphates to the corresponding deoxynucleotides supplying the dNTPs required for DNA re
197 n of replication origin firing, promotion of deoxynucleotide synthesis and replication fork restart,
198 at the sample solution components (chloride, deoxynucleotides, template DNA) and injection conditions
199 P (residues 283-341) bound to a 21-base pair deoxynucleotide that encompasses the canonical 8-base pa
200 ymphoid development and aberrant pools of 2'-deoxynucleotides that are substrates for TdT in lymphoid
201 NR) catalyze the reduction of nucleotides to deoxynucleotides through a mechanism involving an essent
202 ditions that permitted polymerization of one deoxynucleotide to primers containing either 3'-penultim
203 ct stages, i.e., the attachment of the first deoxynucleotide to RT (initiation) and the subsequent ad
204 NA-DNA junction (formed upon attachment of a deoxynucleotide to the RNA primer).
205 ic DNA polymerase alpha, adding a stretch of deoxynucleotides to the RNA primer before handoff to Pol
206 arious time points using an in situ terminal deoxynucleotide tranferase-mediated dUTP nick-end labeli
207          Pancreata were analyzed by terminal deoxynucleotide tranferase-mediated dUTP nick-end labeli
208 gly, Dpo1 also displays a competing terminal deoxynucleotide transferase (TdT) activity unlike any ot
209     Cell apoptosis was evaluated by terminal deoxynucleotide transferase dUTP nick end labeling stain
210 was obtained by double staining for terminal deoxynucleotide transferase nick end labeling (TUNEL) an
211 tion assay using biotin-16-dUTP and terminal deoxynucleotide transferase showed that TopoIIbeta media
212  human V(D)J recombination, whereas terminal deoxynucleotide transferase, Artemis, and DNA-dependent
213  GATA-3, but did not express Pax-5, terminal deoxynucleotide transferase, or CD3epsilon.
214  situ end-labeling of nicked DNA by terminal deoxynucleotide transferase, with measurements of cellul
215 grammed cell death, demonstrated by terminal deoxynucleotide transferase-mediated deoxyuridine tripho
216  histological injury, the number of terminal deoxynucleotide transferase-mediated deoxyuridine tripho
217 ating hepatocyte apoptosis with the terminal deoxynucleotide transferase-mediated deoxyuridine tripho
218 e aminotransferase levels, positive terminal deoxynucleotide transferase-mediated deoxyuridine tripho
219             Positive TUNEL (in situ terminal deoxynucleotide transferase-mediated dUTP nick end label
220                                     Terminal deoxynucleotide transferase-mediated dUTP nick end label
221 ssessed by activation of caspase-3, terminal deoxynucleotide transferase-mediated dUTP nick end-label
222                            Positive terminal deoxynucleotide transferase-mediated dUTP nick end-label
223 ng areas of infarcted myocardium by terminal deoxynucleotide transferase-mediated dUTP nick end-label
224 s their apoptosis was quantified by terminal deoxynucleotide transferase-mediated dUTP nick-end label
225               Apoptosis assessed by terminal deoxynucleotide transferase-mediated dUTP nick-end label
226 died, and apoptosis was detected by terminal deoxynucleotide transferase-mediated dUTP nick-end label
227 optosis are time-consuming (as with terminal deoxynucleotide transferase-mediated dUTP nick-end label
228 ion, and apoptosis by Annexin V and terminal deoxynucleotide transferase-mediated dUTP nick-end label
229 nohistochemistry), apoptotic rates (terminal deoxynucleotide transferase-mediated dUTP nick-end label
230 lografts were examined by using the terminal deoxynucleotide transferase-mediated dUTP nick-end label
231 d interleukin (IL)-10 proteins, and terminal deoxynucleotide transferase-mediated dUTP nick-end label
232  and apoptosis was measured using a terminal deoxynucleotide transferase-mediated dUTP nick-end label
233                                     Terminal deoxynucleotide transferase-mediated dUTP nick-end label
234 e dead tumor cells were swollen and terminal deoxynucleotide transferase-mediated dUTP nick-end label
235 let cell apoptosis was evaluated by terminal deoxynucleotide transferase-mediated dUTP nick-end label
236  cardiomyocytes determined with the terminal deoxynucleotide transferase-mediated dUTP nick-end label
237 and neoplastic pituitary tissues by terminal deoxynucleotide transferase-mediated dUTP nick-end label
238 activated caspase-3, phiphilux, and terminal deoxynucleotide transferase-mediated dUTP nick-end label
239                            Finally, terminal deoxynucleotide transferase-mediated dUTP nick-end label
240                   We demonstrate by terminal deoxynucleotide transferase-mediated dUTP-biotin nick-en
241 mal transport activity, implying that failed deoxynucleotide transport across the inner mitochondrial
242         Our data indicate that mitochondrial deoxynucleotide transport may be essential for prenatal
243  tested if the drim2 gene also encodes for a deoxynucleotide transporter in the fruit fly.
244 o acid that lies above the nucleobase of the deoxynucleotide triphosphate (dNTP) and is expected to p
245  RNA template-DNA primer duplex and incoming deoxynucleotide triphosphate (dNTP) at 3.0-A resolution.
246  primer, and DNA template in the presence of deoxynucleotide triphosphate (dNTP) complementary to the
247                                              Deoxynucleotide triphosphate (dNTP) concentrations have
248 se controlling the size of the intracellular deoxynucleotide triphosphate (dNTP) pool, a limiting fac
249 -121.6-fold lower binding affinity (K(d)) to deoxynucleotide triphosphate (dNTP) substrates than HIV-
250 n Arg668 and the ring oxygen of the incoming deoxynucleotide triphosphate (dNTP) using a combination
251 he 3'-OH on the sugar moiety of the incoming deoxynucleotide triphosphate (dNTP), we examined how thi
252  compounds are competitive inhibitors of the deoxynucleotide triphosphate (dNTP).
253 cation blocker alpha-amanitin, NTPs (but not deoxynucleotide triphosphate [dNTPs]) templated at downs
254 lon nor theta influenced the Km of alpha for deoxynucleotide triphosphate and only slightly decreased
255 ginine 67 are functionally equivalent to the deoxynucleotide triphosphate binding residues arginine 5
256             These agents cause imbalances in deoxynucleotide triphosphate levels and the accumulation
257  whose products supply the mitochondria with deoxynucleotide triphosphate pools needed for DNA replic
258 de reductase and the consequent depletion of deoxynucleotide triphosphate pools result in a cellular
259 r the removal of HAP from purine pools, from deoxynucleotide triphosphate pools, and from DNA, and we
260 lls into S-phase under conditions of altered deoxynucleotide triphosphate pools, particularly an incr
261                    Mus81 enables survival of deoxynucleotide triphosphate starvation, UV radiation, a
262 nterococcus faecalis is a distant homolog of deoxynucleotide triphosphate triphosphohydrolases (dNTPa
263 th protonation of the gamma-phosphate of the deoxynucleotide triphosphate(dNTP) via a solvent water m
264 ernary complex of enzyme*gapped DNA*dNTP (2'-deoxynucleotide triphosphate).
265 ed because the reaction lacked the requisite deoxynucleotide triphosphate.
266 nus to the alpha-beta bridging oxygen of the deoxynucleotide triphosphate; this neutralizes the evolv
267 ested to play an important role in supplying deoxynucleotide triphosphates (dNTP) for DNA repair duri
268                                              Deoxynucleotide triphosphates (dNTPs) are essential for
269 ductase (RNR) supplies the balanced pools of deoxynucleotide triphosphates (dNTPs) necessary for DNA
270 tial event in the HIV-1 life cycle, requires deoxynucleotide triphosphates (dNTPs) to fuel DNA synthe
271 -limiting enzyme in the de novo synthesis of deoxynucleotide triphosphates (dNTPs), is a potential ta
272 etroviral RNA into DNA by depleting cellular deoxynucleotide triphosphates (dNTPs).
273  to detect the template-dependent binding of deoxynucleotide triphosphates by DNA polymerases.
274 ype oligonucleotides were mixed with various deoxynucleotide triphosphates in the presence of Sr(2)(+
275 ent with the high ratio of ribonucleotide to deoxynucleotide triphosphates in tissues, and that riboa
276 bstrate was observed in reactions containing deoxynucleotide triphosphates required to make full-leng
277 in myeloid cells by hydrolyzing the cellular deoxynucleotide triphosphates to a level below that whic
278 orrelated with a rapid decrease in available deoxynucleotide triphosphates.
279 novel checkpoint responsive to low levels of deoxynucleotide triphosphates.
280 e show that SAMHD1 contains a dGTP-regulated deoxynucleotide triphosphohydrolase.
281                                              Deoxynucleotide triphosphohydrolases (dNTPases) play a c
282 to catalyze the conversion of nucleotides to deoxynucleotides under aerobic conditions, and recent st
283 to purine precursors, which would lead to 2'-deoxynucleotides upon desulfurization.
284  reductase (RNR) catalyzes the production of deoxynucleotides using complex radical chemistry.
285 P at the 3'-terminus and the adjacent normal deoxynucleotide was cleaved by DNA polymerase epsilon, t
286      The rate of excision of the 3'-terminal deoxynucleotide was similar, with both primers resulting
287 concentration of salts (chloride and di- and deoxynucleotides) was decreased below 10 microM using ge
288                                          The deoxynucleotides were characterized via steady-state kin
289      In 2 of 14 mutant integrants sequenced, deoxynucleotides were deleted from either the U5 or U3 t
290 acid determinants of the action of PGK for L-deoxynucleotides were not the same as for the D-deoxynuc
291 ver, 3'-terminal dAMP and subsequently other deoxynucleotides were readily excised from DNA in a dist
292 pol gamma in vitro as efficiently as natural deoxynucleotides, whereas AZT-TP, 3TC-TP, and CBV-TP wer
293                          8,5'-Cyclopurine-2'-deoxynucleotides, which are strong blocks to mammalian D
294                       Substitution of the 3'-deoxynucleotide with a ribonucleotide, 2'-methoxyethyl n
295 on in DNA indicates that the substitution of deoxynucleotide with ribonucleotide abolishes the need f
296 pol eta has a low fidelity, misincorporating deoxynucleotides with a frequency of about 10(-2) to 10(
297 yses and find that hPoltheta misincorporates deoxynucleotides with a frequency of about 10(-3) to 10(
298 oli can initiate reduction of nucleotides to deoxynucleotides with either a Mn(III)2-tyrosyl radical
299 obes containing 2'-O-methylnucleotides or 2'-deoxynucleotides with regard to their use in assays for
300 e couple the reduction of ribonucleotides to deoxynucleotides with the oxidation of formate to CO2.

 
Page Top